Fan Xuegong - Director
2014/4/29 10:37:28
Source:     Author:     Clicks: 

Fan Xuegong, M.D., professor of Infectious Diseases, senior consultant, doctorial supervisor, vice president of Xiangya Hospital Central South University, director of National Institution of Drug Clinical Trial  and Phase I Clinical Trial Center at Xiangya Hospital, Central South University.

 

He focuses on the diagnosis and treatment of infectious diseases and management of medical education. He graduated from Chongqing Medical University in 1982 and then worked in the 1st Affiliated Hospital of former Hunan Medical College (now Xiangya Medical College, Central South University). He earned his Master’s degree in 1987 and doctorate degree in 1992. From 1992 to 1995, he did his post-doctoral research in St. James’s Hospital of Dublin University, Ireland. From 1998 to 2001, he studied at the Institute of Microbiology, University of Basel, Switzerland and the University of Texas Medical Branch (UTMB), USA as a visiting scientist. In 2001, he was appointed as vice-president of Xiangya Hospital. 

 

He is a national teaching master, head of the National Excellent Course “Infectious Diseases” and an academic leader in the education of Internal Medicine.

 

He is the director of the Key Laboratory of Viral Hepatitis in Hunan Province, chairman of Hunan Infectious Diseases Society of Chinese Medical Association, vice chairman of Hunan Liver Diseases Society of Chinese Medical Association, and a commissioner of Liver Diseases Society of Chinese Medical Association. He is the editor-in-chief or editorial board member of more than 10 medical journals, chief editor of textbook “Emerging Infectious Diseases”, and an editorial board member of textbook “Infectious Diseases” for 7-year and 8-year medical programs. In the past 5 years, he undertook 4 projects funded by the Natural Science Foundation of China and 1 National New Drug Innovation project. He has won 15 awards in scientific research or teaching at the provincial or ministerial level and holds 2 national invention patents. He has published more than 200 papers, 30 of which were SCI cited.

 

He is an expert of infectious diseases and liver diseases, with abundant experience in the diagnosis and treatment of viral hepatitis, central nervous system infection, etc.


Previous: 
no data.
Next: 

Related Articles